Impact News +++ Vontier Reports Strong Fourth Quarter and Full Year 2025 Results and Initiates Full Year 2026 Guidance (Business Wire) +++ VONTIER Aktie +3,17%

ORION CORP Aktie

>ORION CORP Aktienkurs

67.7 EUR -9.7% (TradegateBSX)

Ask: 68.3 EUR / 80 Stück

Bid: 68.2 EUR / 80 Stück

Tagesumsatz: 233 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ORION CORP Aktie über LYNX handeln

Intraday

1 Jahr

>ORION CORP Performance

1 Woche: +3,8%

1 Monat: +13,0%

3 Monate: +24,6%

6 Monate: +12,2%

1 Jahr: +43,2%

laufendes Jahr: +16,8%

>ORION CORP Aktie

Name:

ORION CORP. B

Land:

Finnland

Sektor:

Gesundheit

ISIN/ Wkn:

FI0009014377 / A0J3QM

Symbol/ Ticker:

OFK (Frankfurt)

Kürzel:

FRA:OFK, ETR:OFK, OFK:GR

Index:

Webseite:

https://www.orion.fi/

Profil:

Orion Oyj Class B represents the publicly traded C..
>Volltext..

Marktkapitalisierung:

10440.47 Mio. EUR

Unternehmenswert:

10527.77 Mio. EUR

Umsatz:

1606.5 Mio. EUR

EBITDA:

478.67 Mio. EUR

Nettogewinn:

308.86 Mio. EUR

Gewinn je Aktie:

2.2 EUR

Schulden:

307.08 Mio. EUR

Liquide Mittel:

221.09 Mio. EUR

Operativer Cashflow:

318.82 Mio. EUR

Bargeldquote:

0.41

Umsatzwachstum:

13.99%

Gewinnwachstum:

-5.58%

Dividende je Aktie:

1.64 EUR

Dividendenrendite:

2.21%

Dividendenschätzung:

2.21%

Div. Historie:

15.10.25 - 0.82€
04.04.25 - 0.82€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

ORION CORP, ORION OYJ, ORION CORPORATION

Letzte Datenerhebung:

12.02.26

>ORION CORP Kennzahlen

Aktien/ Unternehmen:

Aktien: 109.17 Mio. St.

Frei handelbar: 97.19%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: 3712

Umsatz/Mitarb.: 0.36 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: -1.21%

Bewertung:

KGV: 33.41

KGV lG: 20.3

KUV: 6.42

KBV: 10.27

PEG-Ratio: -

EV/EBITDA: 21.99

Rentabilität:

Bruttomarge: 59.67%

Gewinnmarge: 19.23%

Operative Marge: 23.89%

Managementeffizenz:

Gesamtkaprendite: 18.67%

Eigenkaprendite: 32.23%

>ORION CORP Peer Group

Gesundheit, Antikörper- Behandlung, Onkologie/ Krebs- Behandlung

>ORION CORP Chart & Kurs - Tradegate

>ORION CORP News

12.02.26 - 12:15	The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company′s key persons (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE12 FEBRUARY 2026 at 13.12 EET ...

12.02.26 - 11:09	Notice to the Annual General Meeting of Orion Corporation (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / NOTICE TO GENERAL MEETING 12 FEBRUARY 2026 at 12:05 EET...

12.02.26 - 11:03	Orion Group Financial Statement Release January–December 2025 (GlobeNewswire EN)
	ORION CORPORATION FINANCIAL STATEMENT RELEASE 1–12/2025 12 FEBRUARY 2026 at 12:00 EET...

03.02.26 - 08:03	62,752 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 3 FEBRUARY 2026 at 9.00 EET ...

30.01.26 - 08:33	Orion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026 (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 30 JANUARY 2026 at 9.30 EET ...

20.01.26 - 07:33	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS20 January 2026 at 08.30 EET ...

16.01.26 - 08:33	182,827 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 16 JANUARY 2026 at 9:30 EET ...

15.01.26 - 15:33	Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE15 JANUARY 2026 at 16:30 EET...

14.01.26 - 15:03	Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE 14 JANUARY 2026 at 16:00 EET ...

14.01.26 - 09:36	Bayer-Partner Orion mit Top-Prognose – AKTIONÄR-Tipp geht steil (Der Aktionaer)
	Nubeqa (Darolutamid) trifft weiterhin auf eine rege Nachfrage. Das Prostatakrebs-Medikament, welches von der finnischen Orion Corporation an das DAX-Unternehmen Bayer vor vielen Jahren auslizenziert wurde, steht vor weiterem, dynamischem Wachstum. Das unterstreicht eine Prognose, die Orion dem Kapitalmarkt am Mittwoch an die Hand gegeben hat....

14.01.26 - 07:33	Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at 8:30 EET ...

13.01.26 - 15:33	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS13 January 2026 at 16.30 EET ...

12.01.26 - 14:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS12 January 2026 at 15:00 EET ...

09.01.26 - 15:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS9 January 2026 at 16:00 EET ...

08.01.26 - 11:03	Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET ...

07.01.26 - 15:33	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 JANUARY 2026 at 16:30 EET ...

31.12.25 - 12:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS31 December 2025 at 13.00 EET ...

30.12.25 - 13:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 December 2025 at 14:00 EET ...

23.12.25 - 15:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS23 December 2025 at 16.00 EET ...

15.12.25 - 13:36	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS15 December 2025 at 14.30 EET ...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Mag alles Leid und Schatten sein - doch diese süße Sonnenstunde nicht, und nicht der Duft vom roten Klee, und nicht das tiefe, zarte Wohlgefühl in meiner Seele. - Hermann Hesse

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram